Intracranial hemorrhage

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 9, 2011, Pages 998-1006

  Naidech, Andrew M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cerebral hemorrhage; Intracranial hemorrhage; Outcomes; Subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CLOPIDOGREL; COCAINE; DABIGATRAN; DESMOPRESSIN; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; NIMODIPINE; PARACETAMOL; PHENYTOIN; PRAVASTATIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN INHIBITOR; TROPONIN I; VASODILATOR AGENT; WARFARIN;

AGING; ANEMIA; ANEURYSM CLIP; ANEURYSM SURGERY; ANTICOAGULANT THERAPY; ANTICONVULSANT THERAPY; BLOOD CLOTTING DISORDER; BLOOD PRESSURE REGULATION; BLOOD TRANSFUSION; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN VASOSPASM; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COCAINE DEPENDENCE; COGNITIVE DEFECT; COMA; COMPUTER ASSISTED TOMOGRAPHY; COOL AIR BLANKET; COOL WATER BLANKET; COOLING; CRITICALLY ILL PATIENT; DECOMPRESSION SURGERY; DEVICE; DISEASE SEVERITY; DRUG INTOXICATION; ELECTROENCEPHALOGRAM; ERYTHROCYTE TRANSFUSION; FAMILY HISTORY; FEVER; GLASGOW COMA SCALE; HEART ATRIUM FIBRILLATION; HUMAN; HYDROCEPHALUS; HYPERTENSION; HYPOFIBRINOGENEMIA; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL PRESSURE MONITORING; LIVER FAILURE; LOW DRUG DOSE; LUNG EDEMA; MYCOTIC ANEURYSM; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROSURGERY; PALLIATIVE THERAPY; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SCORING SYSTEM; SEIZURE; SEPSIS; STROKE; STUNNED HEART MUSCLE; SUBARACHNOID HEMORRHAGE; THROMBOCYTE TRANSFUSION; TOBACCO; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VASCULAR AMYLOIDOSIS;

HUMANS; INTENSIVE CARE; INTRACRANIAL HEMORRHAGES; MYOCARDIAL STUNNING; PULMONARY EDEMA; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 81055139622     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201103-0475CI     Document Type: Review

References (116)

1. Delgado Almandoz JE, Yoo AJ, StoneMJ, Schaefer PW, Goldstein JN, Rosand J, Oleinik A, Lev MH, Gonzalez RG, Romero JM. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke 2009;40:2994-3000.
2. Mayer SA, Bernardini GL, Solomon RA. Subarachnoid hemorrhage. In: Rowland LP, Pedley TA, editors. Merritt's neurology, 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
3. van der Schaaf IC, Velthuis BK, Gouw A, Rinkel GJE. Venous drainage in perimesencephalic hemorrhage. Stroke 2004;35:1614-1618. (Pubitemid 38823635)
4. Josephson CB, Frantzias J, Samarasekera N, Al-Shahi Salman R. The persisting burden of intracerebral haemorrhage: can effective treatments be found? PLoS Med 2010;7:e1000353.
5. He J, Whelton PK, Vu B, Klag M. Aspirin and the risk of hemorrhage stroke: a meta-analysis of randomized controlled trials. JAMA 1998;280:1930-1935. (Pubitemid 28559811)
6. Knudsen KARJ, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001;56:537-539. (Pubitemid 32172884)
7. Wermer MJH, van der Schaaf IC, Algra A, Rinkel GJE. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke 2007;38:1404-1410. (Pubitemid 351664233)
8. Greving JP, Rinkel GJE, Buskens E, Algra A. Cost-effectiveness of preventive treatment of intracranial aneurysms. Neurology 2009;73:258-265.
9. Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, Morgenstern LB, Wilterdink JL, Horwitz RI. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke 2003;34:1375-1381. (Pubitemid 36693501)
10. Broderick JP, Brown RD Jr, Sauerbeck L, Hornung R, Huston J III, Woo D, Anderson C, Rouleau G, Kleindorfer D, Flaherty ML, et al.; FIA Study Investigators. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke 2009;40:1952-1957.
11. Ishibashi T, Murayama Y, Urashima M, Saguchi T, Ebara M, Arakawa H, Irie K, Takao H, Abe T. Unruptured intracranial aneurysms: incidence of rupture and risk factors. Stroke 2009;40:313-316.
12. Burns JD, Huston J III, Layton KF, Piepgras DG, Brown RD Jr. Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke 2009;40:406-411.
13. de Rooij NK, Linn FHH, van der Plas JA, Algra A, Rinkel GJE. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365-1372. (Pubitemid 350221419)
14. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-1451.
15. CAPRIE steering committee. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet 1996;348:1329-1339.
16. Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, Uchiyama S, Gotoh J, Nagao T, Yamamoto M, et al. Bleeding with Antithrombotic Therapy Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke 2008;39:1740-1745.
17. Wu TC, Kasam M, Harun N, Hallevi H, Bektas H, Acosta I, Misra V, Barreto AD, Gonzales NR, Lopez GA, et al. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke 2011;42:705-709.
18. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 2006;37:256-262. (Pubitemid 43732088)
19. Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CLM, Edinburgh Stroke Study Group, Sorimachi T, Werring DJ, Gregoire SM, Imaizumi T, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010;41:1222-1228.
20. Algra A, De Schryver EL, van Gijn J, Kapelle LJ, Koudstaal PJ. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Cochrane Database Syst Rev [serial on the Internet]. 2006 [accessed July 2011];3:CD001342. Available from http://www.cochrane.org/reviews/clibintro.htm
21. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
22. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-1703.
23. Bluhmki E, Chamorro A, Davalos A, Machnig T, Sauce C, Wahlgren N, Wardlaw J, Hacke W. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 2009;8:1095-1102.
24. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
25. Derex L, Hermier M, Adeleine P, Pialat J.-B, Wiart M, Berthezène Y, Philippeau F, Honnorat J, Froment J-C, Trouillas P, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005;76:70-75. (Pubitemid 40013493)
26. Alshekhlee A, Mohammadi A, Mehta S, Edgell RC, Vora N, Feen E, Kale S, Shakir ZA, Cruz-Flores S. Is thrombolysis safe in the elderly?: Analysis of a national database. Stroke 2010;41:2259-2264.
27. Mateen FJ, Buchan AM, Hill MD; CASES Investigators. Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians. Stroke 2010;41:1833-1835.
28. Yong M, Kaste M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. Stroke 2008;39:366-372. (Pubitemid 351619457)
29. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009;40:2442-2449.
30. Diedler J, Ahmed N, Sykora M, Uyttenboogaart M, Overgaard K, Luijckx G-J, Soinne L, Ford GA, Lees KR, Wahlgren N, et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke 2010;41:288-294.
31. Scott PA, Frederiksen SM, Kalbfleisch JD, Xu Z, Meurer WJ, Caveney AF, Sandretto A, Holden AB, Haan MN, Hoeffner EG, et al. Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med 2010;17:1062-1071.
32. Goldstein JN, Marrero M, Masrur S, Pervez M, Barrocas AM, Abdullah A, Oleinik A, Rosand J, Smith EE, Dzik WH, et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol 2010;67:965-969.
33. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, et al. Acute Liver Failure Study Group. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007;35:2498-2508. (Pubitemid 351339009)
34. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;341:157-158. (Pubitemid 23029318)
35. Kannoth S, Thomas SV, Nair S, Sarma PS. Proposed diagnostic criteria for intracranial infectious aneurysms. J Neurol Neurosurg Psychiatry 2008;79:943-946.
36. Kannoth S, Iyer R, Thomas SV, Furtado SV, Rajesh BJ, Kesavadas C, Radhakrishnan VV, Sarma PS. Intracranial infectious aneurysm: presentation, management and outcome. J Neurol Sci 2007;256:3-9. (Pubitemid 46560618)
37. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81-84.
38. Wijdicks EFM, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol 2005;58:585-593. (Pubitemid 41377222)
39. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870. (Pubitemid 19188240)
40. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14-20.
41. Julien JS, Bandeen-Roche K, Tamargo RJ. Validation of an aneurysmal subarachnoid hemorrhage grading scale in 1532 consecutive patients. Neurosurgery 2008;63:204-211.
42. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES, Mayer SA. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher Scale revisited. Stroke 2001;32:2012-2020. (Pubitemid 32868089)
43. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, Atkinson JL, Wijdicks EF. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-1866. (Pubitemid 38971866)
44. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891-897.
45. Weimar C, Benemann J, Diener H-C. Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry 2006;77:601-605. (Pubitemid 43844582)
46. Rost NS, Smith EE, Chang Y, Snider RW, Chanderraj R, Schwab K, FitzMaurice E, Wendell L, Goldstein JN, Greenberg SM, et al.; Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 2008;39:2304-2309.
47. Dennis LJ, Mayer SA. Diagnosis and management of increased intracranial pressure. Neurol India 2001;49:S37-S50.
48. Kamel H, Navi BB, Nakagawa K, Hemphill JC III, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011;39:554-559.
49. Koenig MA, Bryan M, Lewin JL III, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008;70:1023-1029. (Pubitemid 351451321)
50. Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology 2003;60:837-841. (Pubitemid 36297370)
51. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000;54:354-361. (Pubitemid 30078066)
52. Todd MM, Hindman BJ, Clarke WR, Torner JC, Weeks JB, Bayman EO, Shi Q, Spofford CM. Perioperative fever and outcome in surgical patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2009;64:897-908, discussion 908.
53. Fernandez A, Schmidt JM, Claassen J, Pavlicova M, Huddleston D, Kreiter KT, Ostapkovich ND, Kowalski RG, Parra A, Connolly ES, et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology 2007;68:1013-1019. (Pubitemid 46569135)
54. den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DW. The Paracetamol (Acetaminophen) in Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009;8:434-440.
55. Mayer S, Commichau C, Scarmeas N, Presciutti M, Bates J, Copeland D. Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients. Neurology 2001;56:292-298. (Pubitemid 32144137)
56. Mayer SA, Kowalski RG, Presciutti M, Ostapkovich ND, McGann E, Fitzsimmons BF, Yavagal DR, Du YE, Naidech AM, Janjua NA, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med 2004;32:2508-2515. (Pubitemid 39648236)
57. Diringer MN. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004;32:559-564. (Pubitemid 38234141)
58. Badjatia N, Strongilis E, Gordon E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Ostapkovich ND, Mayer SA. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke 2008;39:3242-3247.
59. Badjatia N, Fernandez L, Schmidt JM, Lee K, Claassen J, Connolly ES, Mayer SA. Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study. Neurosurgery 2010;66:696-700; discussion 700-691.
60. Anderson C, Huang Y, Wang J, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons M, Kim J, et al. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008;7:391-399.
61. Prabhakaran S, Gupta R, Ouyang B, John S, Temes RE, Mohammad Y, Lee VH, Bleck TP. Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study. Stroke 2010;41:89-94.
62. Garg RK, Liebling SM, Maas MB, Nemeth AJ, Russell EJ, Naidech AM. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke (In press)
63. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, Macdonald RL, Messe SR, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41:2108-2129.
64. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH; STICH Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005;365:387-397. (Pubitemid 40179225)
65. Flibotte J, Hagan N, O'Donnell J, Greenberg S, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004;63:1059-1064. (Pubitemid 39287915)
66. Huttner HB, Schellinger PD, Hartmann M, Kohrmann M, Juettler E, Wikner J, Mueller S, Meyding-Lamade U, Strobl R, Mansmann U, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006;37:1465-1470. (Pubitemid 44305727)
67. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen E, Hillborm M. Regular aspirin use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 2006;37:129-133. (Pubitemid 43732060)
68. Thompson BB, Bejot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K, Giroud M, Greenberg SM, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010;75:1333-1342.
69. Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Reduced platelet activity is associated with early clot growth and worse 3 month outcome after intracerebral hemorrhage. Stroke 2009;40:2398-2401.
70. Hillbom M, Huhtakangas J. Platelet transfusion in acute intracerebral hemorrhage [clinical trial no. NCT00699621]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00699621?term= platelet+transfusion+intracerebral+hemorrhage&recr=Open&rank=1
71. de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, Vermeulen M, Roos YB. PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol 2010;10:19.
72. Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 2007;82:731-735. (Pubitemid 47221656)
73. Flordal PA, Sahlin S. Use of desmopressin to prevent bleeding complications in patients treated with aspirin. Br J Surg 1993;80:723-724. (Pubitemid 23197719)
74. Beck KH, Mohr P, Bleckmann U, Schweer H, Kretschmer V. Desmopressin effect on acetylsalicylic acid impaired platelet function. Semin Thromb Hemost 1995;21:32-39.
75. Piriyawat P, Morgenstern LB, Yawn DH, Hall CE, Grotta JC. Treatment of acute intracerebral hemorrhage with e-aminocaproic acid: a pilot study. Neurocrit Care 2004;1:47-51.
76. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer M, Skolnick BE, Steiner T. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.
77. Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127-2137. (Pubitemid 351679599)
78. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000;32:536-541.
79. Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. J Hepatol 2004;41:89-96. (Pubitemid 39005158)
80. Naidech AM, Garg RK, Liebling S, Levasseur K, Macken MP, Schuele SU, Batjer HH. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke 2009;40:3810-3815.
81. Messe SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care 2009;11:38-44.
82. Kumar MA, Rost NS, Snider RW, Chanderraj R, Greenberg SM, Smith EE, Rosand J. Anemia and hematoma volume in acute intracerebral hemorrhage. Crit Care Med 2009;37:1442-1447.
83. Sheth KN, Gilson AJ, Chang Y, Kumar MA, Rahman RM, Rost NS, Schwab K, Cortellini L, Goldstein JN, Smith EE, Greenberg SM, Rosand J. Packed red blood cell transfusion and decreased mortality in intracerebral hemorrhage. Neurosurgery 2011;68:1286-1292.
84. Zahuranec DB, Morgenstern LB, Sanchez BN, Resnicow K,White DB, Hemphill JC III. Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurology 2010;75:626-633.
85. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994-1025.
86. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 2002;97:771-778. (Pubitemid 35222396)
87. Starke RM, Kim GH, Fernandez A, Komotar RJ, Hickman ZL, Otten ML, Ducruet AF, Kellner CP, Hahn DK, ChwajolM, et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke 2008;39:2617-2621.
88. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001;32:1176-1180. (Pubitemid 32825805)
89. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000;31:383-391. (Pubitemid 30078170)
90. Naidech AM, Jovanovic B, Wartenberg KE, Parra A, Ostapkovich N, Connolly ES, Mayer SA, Commichau C. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med 2007;35:2383-2389. (Pubitemid 47476238)
91. Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, Quintel M, Schmiedek P, Vajkoczy P. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 2007;35:1844-1851; quiz 1852.
92. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD000277.
93. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627-1632. (Pubitemid 41098752)
94. Smith MJ, Stiefel MF, Magge S, Frangos S, Bloom S, Gracias V, Le Roux PD. Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 2005;33:1104-1108. (Pubitemid 40638186)
95. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke 2009;40:3039-3044.
96. Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med 2006;34:196-202. (Pubitemid 43032397)
97. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 2008;36:2070-2075.
98. Naidech AM, Shaibani A, Garg RK, Duran IM, Liebling SM, Bassin SL, Bendok BR, Bernstein RA, Batjer HH, Alberts MJ. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care 2010;13:313-320.
99. Naidech AM, Liebling SM, Duran IM, Ault ML. Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage. Transfus Med 2011;21:130-133.
100. Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, Brown S, Kirkpatrick PJ. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial. J Neurosurg 2009;111:171-180.
101. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009;40:e647-e656.
102. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ, Burton P, Klausner MA, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007;357:965-976. (Pubitemid 47367076)
103. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-548. (Pubitemid 40204667)
104. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF. Tako-Tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 2006;105:264-270.
105. Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C, Fitzsimmons BF, Connolly ES, Mayer SA. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005;112:2851-2856. (Pubitemid 41641680)
106. Zaroff JG, Pawlikowska L, Miss JC, Yarlagadda S, Ha C, Achrol A, Kwok PY, McCulloch CE, Lawton MT, Ko N, et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke 2006;37:1680-1685. (Pubitemid 44297712)
107. Claassen J, Hirsch LJ, Frontera JA, Fernandez A, Schmidt M, Kapinos G, Wittman J, Connolly ES, Emerson RG, Mayer SA. Prognostic significance of continuous EEG monitoring in patients with poorgrade subarachnoid hemorrhage. Neurocrit Care 2006;4:103-112. (Pubitemid 43793339)
108. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583-587. (Pubitemid 40352567)
109. Chumnanvej S, Dunn IF, Kim DH. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery 2007;60:99-102, discussion 102-103.
110. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12:165-172.
111. Solomon N, Glick H, Russo C, Lee J, Schulman K. Patient preferences for stroke outcomes. Stroke 1994;25:1721-1725. (Pubitemid 24274961)
112. Christensen MC, Mayer S, Ferran J-M. Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke 2009;40:1677-1682.
113. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2010;41:e519-e536.
114. Casarett D, Fishman JM, MacMoran HJ, Pickard A, Asch DA. Epidemiology and prognosis of coma in daytime television dramas. BMJ 2005;331:1537-1539. (Pubitemid 43015432)
115. Curtis JR, Engelberg RA, Wenrich MD, Shannon SE, Treece PD, Rubenfeld GD. Missed opportunities during family conferences about end-of-life care in the intensive care unit. Am J Respir Crit Care Med 2005;171:844-849. (Pubitemid 40562715)
116. Andrews K. Recovery of patients after four months or more in the persistent vegetative state. BMJ 1993;306:1597-1600. (Pubitemid 23164908)